The intensive follow-up, particularly with frequent blood sampling for tumor markers HE4 and CA125, may have contributed to patient stress and anxiety, especially in cases where rising marker levels suggested an early indication of recurrence without accompanying clinical or radiographic confirmation. The gene discussed is WFDC2; the disease is Anxiety.